Clinical Trial Update: ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating thromboelastographic haemostatic status and antiplatelet therapy after coronary artery bypass graft surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Hypercoagulability
• Thrombosis

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Graft Patency, Coronary Artery Bypass Grafting Surgery | Phase 3 | Status: UNKNOWN